Document is current
Any future updates will be listed below
-
Authors
Goldhardt, Oliver http://orcid.org/0000-0002-3841-3391
Warnhoff, Inanna
Yakushev, Igor
Begcevic, Ilijana
Förstl, Hans
Magdolen, Viktor
Soosaipillai, Antoninus
Diamandis, Eleftherios
Alexopoulos, Panagiotis
Grimmer, Timo
- License Information
-
More Information
Article History
Received: 29 January 2019
Accepted: 13 August 2019
First Online: 27 August 2019
Ethics approval and consent to participate
: The study was approved by the local ethics committee at Technical University of Munich. All subjects included gave written informed consent.
: All subjects included gave written informed consent and all contributing author agreed on the final submitted manuscript.
: The authors report no actual or potential conflict of interest with regards to the submitted work. Outside the submitted work TG reported having received consulting fees from Actelion, Eli Lilly, Iqvia, Quintiles, MSD, Novartis, Quintiles, Roche Pharma, lecture fees from Biogen, Lilly, Parexel, Roche Pharma, and grants to his institution from Actelion and PreDemTech. Outside the submitted work, OG reports having received consulting fees from Eli Lilly, and grants to his institution from Actelion. All further authors declare no competing interests.
